ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 452 filers reported holding ASTRAZENECA PLC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,412,000 | -7.7% | 45,328 | -19.0% | 0.64% | -10.1% |
Q4 2016 | $1,529,000 | -16.9% | 55,990 | 0.0% | 0.72% | -17.5% |
Q3 2016 | $1,839,000 | +8.8% | 55,990 | 0.0% | 0.87% | +11.9% |
Q2 2016 | $1,690,000 | +1.9% | 55,990 | -4.8% | 0.78% | 0.0% |
Q1 2016 | $1,658,000 | -17.0% | 58,827 | 0.0% | 0.78% | -13.5% |
Q4 2015 | $1,997,000 | +6.7% | 58,827 | 0.0% | 0.90% | +8.6% |
Q3 2015 | $1,872,000 | +1.9% | 58,827 | +104.0% | 0.82% | +11.2% |
Q2 2015 | $1,837,000 | +345.9% | 28,831 | +378.5% | 0.74% | +228.3% |
Q1 2015 | $412,000 | -2.8% | 6,025 | 0.0% | 0.23% | +20.9% |
Q4 2014 | $424,000 | -66.6% | 6,025 | -66.1% | 0.19% | -65.0% |
Q3 2014 | $1,269,000 | +11.0% | 17,765 | +15.5% | 0.54% | +8.1% |
Q2 2014 | $1,143,000 | +10.9% | 15,375 | -3.2% | 0.50% | +4.7% |
Q1 2014 | $1,031,000 | +8.2% | 15,885 | -1.1% | 0.47% | -3.3% |
Q4 2013 | $953,000 | +14.3% | 16,055 | 0.0% | 0.49% | +21.6% |
Q3 2013 | $834,000 | +9.9% | 16,055 | 0.0% | 0.40% | +10.1% |
Q2 2013 | $759,000 | – | 16,055 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |